Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

ACRVACRV
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in ACRIVON THERAPEUTICS INC

BANK OF AMERICA CORP /DE/ holds 16,407 shares of ACRV (ACRIVON THERAPEUTICS INC), worth $29,204 as of 2026-Q2. The position was decreased (-0.6% shares).

Current Value

$29,204

Current Shares

16,407

Total Value Change

-$158,054

Total Shares Change

-14,699

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
16,407
-0.6%
$29,2040.0%$1.78
0
2026-Q1
Decreased
16,513
-5.3%
$22,9530.0%$1.67
0
2025-Q4
Decreased
17,447
-7.7%
$42,0480.0%$2.44
0
2025-Q3
Decreased
18,904
-8.3%
$34,2160.0%$1.82
0
2025-Q2
Decreased
20,617
-25.6%
$24,5340.0%$1.20
0
2025-Q1
Decreased
27,699
-10.9%
$56,2290.0%$2.24
0
2024-Q4
New
31,106
-
$187,2580.0%$5.41
35

Other major holders of ACRV: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used